Type
. Leprosy and the elusive M. leprae: colonial and Imperial medical exchanges in the nineteenth century. Historia, ciencias, saude--Manguinhos. 2003;10(Suppl 1):13-40.
Type
. Estimating the relative recurrence risk ratio using a global cross-ratio model. Genetic epidemiology. 2003;25(4):293-302.
Type
. Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions. Clinical and experimental immunology [Internet]. 2003;134(3):447-53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808882/pdf/cei0134-0447.pdf
Type
. Skeletal pathology in a prehistoric Pacific Island sample: issues in lesion recording, quantification, and interpretation. American journal of physical anthropology. 2003;122(4):303-24.
Type
. Human genetics of common mycobacterial infections. Immunologic research. 2003;28(2):109-29.
Type
. "Elimination" of leprosy and the need to sustain leprosy services, expectations, predictions and reality. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2003;71(3):248-56. Available from: http://www.leprosy-ila.org/leprosyjournal/html/71-3/71-3-11.php
Type
. The social dimensions of leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 2003;71(3):246-7. Available from: http://www.leprosy-ila.org/leprosyjournal/html/71-3/71-3-10.php
Type
. Possible roles of anti-Mycobacterium leprae antibodies in suppression of the cell-mediated immune response against M. leprae. Immunology today. 1992;13(12):513.
Type
. Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Molecular and cellular probes. 1992;6(5):401-10.
Type
. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine. Arzneimittel-Forschung. 1992;42(10):1243-5.